Tørring, N., Borre, M., Sørensen, K., Andersen, C. L., Wiuf, C. & Ørntoft, T. F. (2007).
Genome-Wide analysis of allelic imbalance in laser microdissected prostate cancer tissue using the Affymetrix 50K Mapping array identifies genomic patterns associated with metastasis and differentiation.
British Journal of Cancer,
96(3), 499-506.
https://doi.org/10.1038/sj.bjc.6603476
Topcu, S., Pedersen, M., Wang, G., Nørregård, R.
, Djurhuus, J. C., Nielsen, S., Jørgensen, T. M. & Frøkiær, J. (2006).
Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction (PUUO).
Journal of Pediatric Urology,
2, 107-108.
Topcu, S., Pedersen, M., Guixian, W., Knepper, M. A.
, Nielsen, S., Jørgensen, T. M. & Frøkiær, J. (2006).
Candesartan prevents long term changes in response to neonatal ureteral obstruction. Abstract from SVF PhD Day, Aarhus, Denmark.
Topcu, S., Pedersen, M., Wang, G., Nørregård, R.
, Djurhuus, J. C., Nielsen, S., Jørgensen, T. M. & Frøkiær, J. (2006).
Candesartan prevents long-term impariment of renal function in response to neonatal partial unilateral ureteral obstruction (PUUO). Abstract from ESPU 17th Annual Congress, Athens, Greece.
Topcu, S., Pedersen, M., Nørregaard, R., Wang, G., Knepper, M.
, Djurhuus, J. C., Nielsen, S., Jørgensen, T. M. & Frøkiær, J. (2007).
Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.
American Journal of Physiology: Renal Physiology,
292, F736-748.
Topcu, S., Nørregaard, R., Pedersen, M., Wang, G., Jørgensen, T. M. & Frøkiær, J. (2007).
Hemodynamic and molecular changes in the solitary kidney in response to neonatal partial ureteral obstruction. In J. Adolfsson (Ed.),
Ikke angivet (Vol. 41, pp. 17). Scandinavian Journal of Urology and Nephrology.
Topcu, S., Nørregaard, R., Pedersen, M., Wang, G., Jørgensen, T. M. & Frøkiær, J. (2011).
Regulation of aquaporins and sodium transporter proteins in the solitary kidney in response to partial ureteral obstruction in neonatal rats.
Urologia Internationalis,
87(1), 94-104.
https://doi.org/10.1159/000319969
Tombal, B.
, Borre, M., Rathenborg, P., Werbrouck, P., Van Poppel, H., Heidenreich, A.
, Iversen, P., Braeckman, J., Heracek, J., Baskin-Bey, E., Ouatas, T., Perabo, F., Phung, D., Hirmand, M. & Smith, M. R. (2014).
Enzalutamide monotherapy in hormone-naive prostate cancer: primary analysis of an open-label, single-arm, phase 2 study.
Lancet Oncology,
15(6), 592-600.
https://doi.org/10.1016/S1470-2045(14)70129-9Tombal, B.
, Borre, M., Rathenborg, P., Werbrouck, P., Van Poppel, H., Heidenreich, A.
, Iversen, P., Braeckman, J., Heracek, J., Baskin-Bey, E., Ouatas, T., Perabo, F., Phung, D., Baron, B., Hirmand, M. & Smith, M. R. (2015).
Long-term Efficacy and Safety of Enzalutamide Monotherapy in Hormone-naïve Prostate Cancer: 1- and 2-Year Open-label Follow-up Results.
European Urology,
68(5), 787–794.
https://doi.org/10.1016/j.eururo.2015.01.027Tombal, B.
, Borre, M., Rathenborg, P., Werbrouck, P., Van Poppel, H., Heidenreich, A., Iversen, P., Braeckman, J., Heracek, J., Baron, B., Krivoshik, A., Hirmand, M. & Smith, M. R. (2018).
Long-Term Antitumor Activity and Safety of Enzalutamide Monotherapy in Hormone Naïve Prostate Cancer: 3-Year Open Label Followup Results.
Journal of Urology,
199(2), 459-464.
https://doi.org/10.1016/j.juro.2017.08.103Tolbod, L. P., Nielsen, M. M., Harms, H. J., Pedersen, B. G., Borghammer, P., Borre, M., Bouchelouche, K., Frøkiær, J. & Sorensen, J. (2015).
Noninvasive Quantification of Tumor Blood Flow in Prostate Cancer using 82Rb PET/CT.
European Journal of Nuclear Medicine and Molecular Imaging,
42(Suppl. 1), S121-S122.
https://doi.org/10.1007/s00259-015-3198-z
Tolbod, L. P., Nielsen, M. M., Pedersen, B. G., Høyer, S., Harms, H., Borre, M., Borghammer, P., Bouchelouche, K., Frøkiær, J. & Sørensen, J. (2018).
Non-invasive quantification of tumor blood flow in prostate cancer using 15O-H2O PET/CT.
American Journal of Nuclear Medicine and Molecular Imaging,
8(5), 292-302.
http://www.ajnmmi.us/files/ajnmmi0085293.pdf
Thygesen, M., Vondeling, H., Douw, K., Jønler, M.
, Pedersen, K. V. & Mommsen, S. (2007).
Udvikling af en internetsøgestrategi til identifikation af ny medicinsk teknologi inden for prostatacancer. Ugeskrift for Læger,
169(20), 1912-1917.
Thorsen, K., Sørensen, K. D., Brems-Eskildsen, A. S., Modin, C., Gaustadnes, M., Hein, A.-M. K., Kruhøffer, M., Laurberg, S., Borre, M., Wang, K., Brunak, S., Krainer, A. R.
, Tørring, N., Dyrskjøt, L., Andersen, C. L. & Ørntoft, T. F. (2008).
Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
Molecular and Cellular Proteomics,
7(7), 1214-24.
https://doi.org/10.1074/mcp.M700590-MCP200
Thomsen, F. B., Røder, M. A., Rathenborg, P., Brasso, K.
, Borre, M. & Iversen, P. (2013).
Enzalutamide treatment in patients with metastatic castration-resistant prostate cancer progressing after chemotherapy and abiraterone acetate.
Scandinavian Journal of Urology and Nephrology.
https://doi.org/10.3109/21681805.2013.860189